Cargando…

A clinical comparison of etomidate-lipuro, propofol and admixture at induction

OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Saricaoglu, Fatma, Uzun, Sennur, Arun, Oguzhan, Arun, Funda, Aypar, Ulku
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101756/
https://www.ncbi.nlm.nih.gov/pubmed/21655019
http://dx.doi.org/10.4103/1658-354X.76509
_version_ 1782204302199095296
author Saricaoglu, Fatma
Uzun, Sennur
Arun, Oguzhan
Arun, Funda
Aypar, Ulku
author_facet Saricaoglu, Fatma
Uzun, Sennur
Arun, Oguzhan
Arun, Funda
Aypar, Ulku
author_sort Saricaoglu, Fatma
collection PubMed
description OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction was performed with either etomidate-lipuro, propofol or etomidate-lipuro–propofol admixture. After monitorization with bispectral index (BIS) all agents were given with infusion with a perfuser at a constant rate of 200 ml/min till the BIS values decreased to 40. Blood pressure and heart rate were measured every 30 s at this period. Patients were asked for pain at the injection site and observed visually for myoclonus. The time BIS values decreased to 40 (BIS 40 time) and total amounts of induction doses were measured. RESULTS: BIS 40 time measurements were P > E > PE (199.4 ± 40.9, 176.9 ± 31.6, 163.5 ± 20.6 s). The hemodynamic (systolic, diastolic and mean blood pressures, heart rate) changes were minimal in group PE than other two groups (P = 0.017). The intensity of myoclonus was graded as mild in 9, moderate in 12, and severe in 5 patients in the group E (76.3%). Myoclonus was not observed in group PE and group P. There were no injection pain in group PE as the incidence were (83.8%) in group P and in (63.2%) group E. CONCLUSION: Incidence of hemodynamic changes, myoclonus, and injection pain is significantly lower in group PE. BIS 40 times is least in group PE. We concluded that 1:1 admixture of etomidate-lipuro and propofol is a valuable agent for induction.
format Text
id pubmed-3101756
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31017562011-06-08 A clinical comparison of etomidate-lipuro, propofol and admixture at induction Saricaoglu, Fatma Uzun, Sennur Arun, Oguzhan Arun, Funda Aypar, Ulku Saudi J Anaesth Original Article OBJECTIVE: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. METHODS: Ninety patients were assigned at random to three groups in which induction was performed with either etomidate-lipuro, propofol or etomidate-lipuro–propofol admixture. After monitorization with bispectral index (BIS) all agents were given with infusion with a perfuser at a constant rate of 200 ml/min till the BIS values decreased to 40. Blood pressure and heart rate were measured every 30 s at this period. Patients were asked for pain at the injection site and observed visually for myoclonus. The time BIS values decreased to 40 (BIS 40 time) and total amounts of induction doses were measured. RESULTS: BIS 40 time measurements were P > E > PE (199.4 ± 40.9, 176.9 ± 31.6, 163.5 ± 20.6 s). The hemodynamic (systolic, diastolic and mean blood pressures, heart rate) changes were minimal in group PE than other two groups (P = 0.017). The intensity of myoclonus was graded as mild in 9, moderate in 12, and severe in 5 patients in the group E (76.3%). Myoclonus was not observed in group PE and group P. There were no injection pain in group PE as the incidence were (83.8%) in group P and in (63.2%) group E. CONCLUSION: Incidence of hemodynamic changes, myoclonus, and injection pain is significantly lower in group PE. BIS 40 times is least in group PE. We concluded that 1:1 admixture of etomidate-lipuro and propofol is a valuable agent for induction. Medknow Publications 2011 /pmc/articles/PMC3101756/ /pubmed/21655019 http://dx.doi.org/10.4103/1658-354X.76509 Text en © Saudi Journal of Anaesthesia http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saricaoglu, Fatma
Uzun, Sennur
Arun, Oguzhan
Arun, Funda
Aypar, Ulku
A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title_full A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title_fullStr A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title_full_unstemmed A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title_short A clinical comparison of etomidate-lipuro, propofol and admixture at induction
title_sort clinical comparison of etomidate-lipuro, propofol and admixture at induction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101756/
https://www.ncbi.nlm.nih.gov/pubmed/21655019
http://dx.doi.org/10.4103/1658-354X.76509
work_keys_str_mv AT saricaoglufatma aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT uzunsennur aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT arunoguzhan aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT arunfunda aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT ayparulku aclinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT saricaoglufatma clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT uzunsennur clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT arunoguzhan clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT arunfunda clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction
AT ayparulku clinicalcomparisonofetomidatelipuropropofolandadmixtureatinduction